Prescription drug savings from Abbvie
Prescription drugs play a crucial role in improving the health and well-being of individuals. However, the high cost of medications can be a significant barrier for many patients to access the treatments they need. AbbVie, a leading pharmaceutical company, understands the importance of ensuring patients can afford and access the medicines prescribed to them. In this article, we will explore the various patient assistance and support programs offered by AbbVie.
AbbVie’s Patient Assistance Programs
AbbVie’s patient assistance programs are designed to provide free AbbVie medicines to qualifying patients who reside in the United States and have limited or no health insurance coverage. These programs are aimed at individuals who demonstrate a qualifying financial need. In 2022 alone, AbbVie assisted nearly 200,000 people through these programs, ensuring that they could receive the medications they require without the burden of high costs.
Eligibility Criteria for myAbbVie Assist
To be eligible for AbbVie’s myAbbVie Assist program, patients must meet certain criteria:
- Patients must be receiving treatment from a licensed U.S. healthcare provider on an outpatient basis and be prescribed an AbbVie medicine that is included in the assistance program
- Patients should have limited or no health insurance coverage. The program aims to support individuals who face financial difficulties accessing necessary medications due to insufficient insurance coverage
- Patients must demonstrate a qualifying financial need. AbbVie has specific income criteria that determine eligibility for their assistance programs, ensuring that those who genuinely require financial support receive it
- The myAbbVie Assist program is available to individuals who reside in the United States
It is important to note that patients with commercial insurance plans that require them to apply for myAbbVie Assist as a condition for coverage are not eligible for the program.
How to Enroll in myAbbVie Assist
Enrolling in AbbVie’s myAbbVie Assist program is a simple process. Follow these steps to apply for and receive your medication:
- Visit AbbVie’s website and access the list of AbbVie treatments that are eligible for myAbbVie Assist. Review the eligibility information to ensure that your prescribed medication is included
- If you meet the eligibility criteria, complete the provided application form in collaboration with your healthcare provider. Make sure to provide accurate information to avoid any delays in the process
- AbbVie aims to review your application within two days of submission. During this time, they will assess your eligibility based on the criteria mentioned earlier. You and your healthcare provider will be updated on the status of your application
- If you have any questions or need assistance during the application process, you can reach out to AbbVie’s dedicated helpline at 1-800-222-6885. Their team is there to support you and provide guidance
Access to a wide range of medications
The available medicines are listed below, if you are eligible for AbbVie’s myAbbVie Assist program:
- ALLODERM™ Regenerative Tissue Matrix
- Alphagan® P (brimonidine tartrate) ophthalmic solution
- Armour Thyroid® (thyroid tablets, USP) tablets
- Avycaz® (avibactam, ceftazidime) powder
- BOTOX® (onabotulinumtoxinA)
- Canasa® (mesalamine) suppository
- CREON® (pancrelipase) Delayed-Release Capsules
- Crinone® (progesterone) gel
- Dalvance® (dalbavancin) lyophilisate
- Delzicol® (mesalamine DR) capsules
- Depakote® (divalproex sodium)
- DUOPA (carbidopa and levodopa) enteral suspension
- Durysta® (bimatoprost) ocular implant
- Fetzima® (levomilnacipran) Extended Release Capsules and Titration Pack
- GENGRAF®Capsules (cyclosporine capsules, USP [MODIFIED])
- HUMIRA® (adalimumab)
- IMBRUVICA® (ibrutinib)
- KALETRA® (lopinavir/ritonavir) Tablets
- KELLER FUNNEL® 2
- Linzess® (linaclotide) capsules
- Lumigan® (bimatoprost 0.01%) opthalmic solution
- LUPRON DEPOT® (leuprolide acetate for depot suspension)
- LUPRON DEPOT-PED® (leuprolide acetate for depot suspension)
- MAVYRET® (glecaprevir/pibrentasvir)
- Namzaric® (memantine HCl extended-release and donepezil HCl) capsule
- NATRELLE®
- NORVIR® (ritonavir) tablets and oral solution
- Oriahnn™ (elagolix/estradiol/norethindrone acetate)
- ORILISSA™ (elagolix) tablets
- Ozurdex® (dexamethasone) ocular implant
- QULIPTA™ (atogepant) tablets
- Rectiv® (nitroglycerin) ointment
- Restasis® (cyclosporine) ophthalmic emulsion
- REVOLVE™ System Advanced Adipose System
- RINVOQ™ (upadacitinib)
- Saphris® (asenapine maleate) sublingual tablet
- Savella® (milnacipran HCl) tablets
- SKYRIZI™ (risankizumab-rzaa)
- STRATTICE™ and STRATTICE™ BPS Reconstructive Tissue Matrix
- Synthroid® (levothyroxine sodium) tablets
- Teflaro® (ceftaroline fosamil) powder for injection
- Ubrelvy® (ubrogepant) tablets
- VENCLEXTA™ (venetoclax tablets)
- Viberzi® (eluxadoline) tablets
- Viibryd® (vilazodone HCl) tablets
- Vraylar® (cariprazine) capsules
- Xen® Gel Stent
AbbVie Prescription Savings Programs
AbbVie has established various prescription savings cards to assist eligible patients in reducing their out-of-pocket costs. These programs are designed to complement existing insurance coverage and provide significant savings on specific medications:
- Alphagan® P (brimonidine tartrate) ophthalmic solution
- BOTOX® (onabotulinumtoxinA)
- Bystolic® (nebivolol) tablets
- Combigan® (brimonidine tartrate/timolol maleate) opthalmic solution
- Creon® (pancrelipase) Delayed-Release Capsules)
- Crinone® (progesterone) gel
- Dalvance® (dalbavancin) lyophilisate
- Delzicol® (mesalamine DR) capsules
- Depakote
- Duopa
- Durysta® (bimatoprost) ocular implant
- Fetzima® (levomilnacipran) Extended Release Capsules and Titration Pack
- HUMIRA® (adalimumab)
- IMBRUVICA® (ibrutinib)
- Kaletra
- Lo Loestrin® Fe
- Linzess® (linaclotide) capsules
- Lumigan® (bimatoprost 0.01%) opthalmic solution
- Lupron
- MAVYRET® (glecaprevir/pibrentasvir)
- Namzaric® (memantine HCl extended-release and donepezil HCl) capsule
- Norvir
- Oriahann
- Orilissa
- Ozurdex® (dexamethasone) ocular implant
- Pred Forte® (prednisolone acetate) ophthalmic suspension
- QULIPTATM (atogepant) tablets
- Restasis® (cyclosporine) ophthalmic emulsion
- RINVOQ™ (upadacitinib)
- Saphris® (asenapine maleate) sublingual tablet
- Savella® (milnacipran HCl) tablets
- SKYRIZI™ (risankizumab-rzaa)
- Synthroid® (levothyroxine sodium) tablets
- Ubrelvy® (ubrogepant) tablets
- VENCLEXTA™ (venetoclax tablets)
- Viberzi® (eluxadoline) tablets
- Viibryd® (vilazodone HCl) tablets
- Vraylar® (cariprazine) capsules
Conclusion
In conclusion, AbbVie’s patient assistance programs, particularly myAbbVie Assist, offer a lifeline to patients struggling with the high costs of prescription medications. By simplifying the application process and providing free AbbVie medicines to those who qualify, AbbVie is ensuring that patients receive the treatments they need without financial constraints. If you or someone you know meets the eligibility criteria, don’t hesitate to explore the options available through AbbVie’s patient assistance programs. Take the first step towards affordable and accessible medications today. Visit AbbVie website for more information.
Sources
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111